Evaluation of reversibility of pulmonary hypertension in heart transplant candidates

被引：0
|
作者：
Delgado, RM
Radovancevic, B
Thomas, CD
Kar, B
Radovancevic, R
Torre-Amione, G
Frazier, OH
机构：
[1] Texas Heart Inst, Houston, TX 77025 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1975
引用
收藏
页码：428 / 428
页数：1
相关论文
共 50 条
  • [41] Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates
    Radovancevic, B
    Vrtovec, B
    Thomas, CD
    Croitoru, M
    Myers, TJ
    Radovancevic, R
    Khan, T
    Massin, EK
    Frazier, OH
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (06): : 690 - 695
  • [42] Prognostic value and usefulness of Pulmonary Artery Pulsatility index (PAPi) in evaluation of heart transplant candidates
    Bellettini, M.
    Pidello, S.
    Gallone, G.
    Frea, S.
    Masetti, M.
    Sabatino, M.
    Boschi, S.
    Giustetto, C.
    Boffini, M.
    Rinaldi, M.
    Potena, L.
    De Ferrari, G. M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1104 - 1104
  • [43] Mechanical circulatory support is effective to treat pulmonary hypertension in heart transplant candidates disqualified due to unacceptable pulmonary vascular resistance
    Zakliczynski, Michal
    Pacholewicz, Jerzy
    Copik, Izabela
    Maruszewski, Marcin
    Hrapkowicz, Tomasz
    Przybylski, Roman
    Zembala, Marian
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA, 2018, 15 (01): : 23 - 26
  • [44] Successful Evaluation for Reversibility of Pulmonary Hypertension Using Inhaled Nitric Oxide Determining Candidate for Heart Transplantation
    Omote, Kazunori
    Sakakibara, Mamoru
    Nanbu, Hideo
    Maekawa, Satoshi
    Asakawa, Naoya
    Noguchi, Keiji
    Tokuda, Yusuke
    Kamiya, Kiwamu
    Kinugawa, Shintaro
    Tsutsui, Hiroyuki
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S228 - S229
  • [45] Inhaled nitric oxide through a noninvasive ventilation device to assess reversibility of pulmonary hypertension in selecting recipients for heart transplant
    Fojón, S
    Fernández-González, C
    Sánchez-Andrade, J
    López-Pérez, JM
    Hermida, LF
    Rodríguez, JA
    Juffé, A
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (09) : 4028 - 4030
  • [46] Predictors of reversibility of pulmonary hypertension in cardiac transplant recipients in the first postoperative year
    Chau, EMC
    Bailey, KR
    Mahoney, DW
    Frantz, RP
    McGregor, CGA
    Daly, RC
    Edwards, BS
    Olson, LJ
    Rodeheffer, RJ
    CIRCULATION, 1996, 94 (09) : 267 - 272
  • [47] Nitric oxide and prostaglandin E1 therapy for heart transplant candidates with secondary pulmonary hypertension.
    Khan, T
    Radovancevic, B
    Thomas, CD
    Croitoru, M
    Myers, TJ
    Radovancevic, R
    Massin, EK
    Frazier, OH
    TRANSPLANTATION, 2000, 69 (08) : S233 - S233
  • [48] Reversible pulmonary hypertension in heart transplant candidates does not obligatorily predict worse outcome post-transplantation
    Klotz, S
    Schmid, C
    Scheld, HH
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (11): : 1998 - 1999
  • [49] Effectiveness of mechanical circulatory support devices in reversing pulmonary hypertension among heart transplant candidates: A systematic review
    Albulushi, Arif
    Al-Riyami, Mohammed B.
    Al-Rawahi, Najib
    Al-Mukhaini, Mohammed
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (07)
  • [50] HOW OFTEN SHOULD LIVER TRANSPLANT CANDIDATES BE SCREENED FOR PULMONARY HYPERTENSION?
    Ramsay, Michael A. E.
    Newman, Kate B.
    Sanchez, Edmund Q.
    Klintmalm, Goran B.
    LIVER TRANSPLANTATION, 2009, 15 (07) : S121 - S122
12345